ID

25733

Beschrijving

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Cognitive Function Substudy.

Trefwoorden

Versies (5)

1. 15-09-17 15-09-17 -
2. 21-09-17 21-09-17 -
3. 13-10-17 13-10-17 -
4. 23-10-17 23-10-17 -
5. 20-12-17 20-12-17 -

Houder van rechten

GlaxoSmithKline

Geüploaded op

15 september 2017

DOI

Voor een aanvraag inloggen.

Licentie